Prime Capital Investment Advisors, LLC Biogen Inc. Transaction History
Prime Capital Investment Advisors, LLC
- $7.33 Billion
- Q2 2025
A detailed history of Prime Capital Investment Advisors, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Prime Capital Investment Advisors, LLC holds 4,055 shares of BIIB stock, worth $629,538. This represents 0.01% of its overall portfolio holdings.
Number of Shares
4,055
Previous 2,636
53.83%
Holding current value
$629,538
Previous $360,000
41.39%
% of portfolio
0.01%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding BIIB
# of Institutions
1,019Shares Held
131MCall Options Held
2.87MPut Options Held
2.57M-
Vanguard Group Inc Valley Forge, PA17.3MShares$2.68 Billion0.04% of portfolio
-
Primecap Management CO Pasadena, CA15.8MShares$2.45 Billion1.62% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$2.26 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.47MShares$1.16 Billion0.04% of portfolio
-
Wellington Management Group LLP Boston, MA4.8MShares$745 Million0.11% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $22.4B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...